SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

10 May 2022 Evaluate
A slight decline in the revenue of Rs. 833.40 millions was seen for the March 2022 quarter as against Rs. 857.80 millions during year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 48.30 millions grew from Rs.-1414.20 millionsThe Operating Profit of the company witnessed a decrease to 145.20 millions from 160.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 833.40 857.80 -2.84 3027.90 2003.20 51.15 3027.90 2003.20 51.15
Other Income 133.00 54.60 143.59 657.10 661.50 -0.67 657.10 661.50 -0.67
PBIDT 145.20 160.70 -9.65 999.00 135.00 640.00 999.00 135.00 640.00
Interest 100.30 102.80 -2.43 372.30 341.70 8.96 372.30 341.70 8.96
PBDT 10.80 57.90 -81.35 567.60 -206.70 -374.60 567.60 -206.70 -374.60
Depreciation 344.90 348.00 -0.89 1400.70 1413.50 -0.91 1400.70 1413.50 -0.91
PBT -334.10 -290.10 15.17 -833.10 -1620.20 -48.58 -833.10 -1620.20 -48.58
TAX -382.40 1124.10 -134.02 -528.40 641.20 -182.41 -528.40 641.20 -182.41
Deferred Tax -75.60 944.40 -108.01 -221.60 461.50 -148.02 -221.60 461.50 -148.02
PAT 48.30 -1414.20 -103.42 -304.70 -2261.40 -86.53 -304.70 -2261.40 -86.53
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 17.42 18.73 -7.00 32.99 6.74 389.57 32.99 6.74 389.57

Dishman Carbogen Amc Share Price

174.60 2.75 (1.60%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×